Sort by
Refine Your Search
-
the goal of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes
-
of improving human health. Aligned with Rutgers University–New Brunswick and collaborating university wide, RBHS includes eight schools, a behavioral health network, and five centers and institutes that focus
-
a health system intervention to improve chronic disease management for cancers survivors receiving cancer treatment. The Postdoctoral Associate will participate in the clinical trial conduct and
-
of transcription factors and the epigenome dynamics. The individual is needed to conduct research on questions related to transcription factor DNA-driven 3D epigenome dynamics in immune responses. By using genetic
-
technical and non-technical (political, behavioral, social) obstacles to building and grid decarbonization. The successful candidate will work with a team of approximately 20 researchers in the built
-
-making, and attaining results. The ability to design, develop, conduct, and manage transportation research, formulate problems and deliver reports on a constant and timely basis are critical. Extremely
-
, collaborate with national and international partners, and contribute to publications and grant development. Responsibilities Conduct bioinformatic analyses of bacterial and fungal amplicon sequencing (16S, ITS
-
needs to conduct research on questions related to powdery mildew resistance and susceptibility in hemp. By using genetic, genomic and biochemical methods, the individual will identify/analyze/characterize
-
, Genetics, or a related field. - Demonstrated expertise in mouse genetics, genotyping, and behavior analysis. - Proficient in a range of laboratory techniques related to neuroscience, genetics, and behavioral
-
for setting up experimental systems to study type VI CRISPR-Cas defense mechanisms and analyzing collateral RNA damage using RNA-sequencing. KEY DUTIES: 60 % 1. Conduct research on RNA-targeting type VI CRISPR